4//SEC Filing
Venker Eric 4
Accession 0001140361-25-043201
CIK 0001635088other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 9:00 PM ET
Size
4.8 KB
Accession
0001140361-25-043201
Insider Transaction Report
Form 4
Venker Eric
President & Immunovant CEO
Transactions
- Tax Payment
Common Shares
2025-11-20$20.27/sh−7,051$142,924→ 1,497,908 total
Footnotes (1)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0001801917
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 9:00 PM ET
- Size
- 4.8 KB